Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer	Metastatic Castration-resistant Prostate Cancer	Recruiting	Phase 1 / Phase 2	2025-04-13		NCT06480110

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Copenhagen University Hospital, Rigshospitalet	330
Danish Cancer Society	34

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Oncology 5073, Rigshospitalet	Copenhagen	Denmark	1

Clinical trials